Management of venous stenosis in living donor liver transplant recipients

被引:6
|
作者
Yang, Jie [1 ]
Xu, Ming-Qing [1 ]
Yan, Lu-Nan [1 ]
Lu, Wu-Sheng [1 ]
Li, Xiao [1 ]
Shi, Zheng-Rong [1 ]
Li, Bo [1 ]
Wen, Tian-Fu [1 ]
Wang, Wen-Tao [1 ]
Yang, Jia-Ying [1 ]
机构
[1] Sichuan Univ, W China Hosp, Dept Liver & Vasc Surg, Chengdu 610041, Sichuan, Peoples R China
关键词
Living donor liver transplantation; Venous obstruction; Anastomotic stenosis; Venoplasty; Stent; PORTAL-VEIN STENOSIS; PERCUTANEOUS TRANSHEPATIC VENOPLASTY; MIDDLE HEPATIC VEIN; OUTFLOW OBSTRUCTION; STENT PLACEMENT; BALLOON ANGIOPLASTY; TISSUE EXPANDER; RECONSTRUCTION; COMPLICATIONS; CHILDREN;
D O I
10.3748/wjg.15.4969
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To retrospectively evaluate the management and outcome of venous obstruction after living donor liver transplantation (LDLT). METHODS: From February 1999 to May 2009, 1 intraoperative hepatic vein (HV) tension induced HV obstruction and 5 postoperative HV anastomotic stenosis occurred in 6 adult male LDLT recipients. Postoperative portal vein (PV) anastomotic stenosis occurred in 1 pediatric left lobe LDLT. Patients ranged in age from 9 to 56 years (median, 44 years). An air balloon was used to correct the intraoperative HV tension. Emergent surgical reoperation, transjugular HV balloon dilatation with stent placement and transfemoral venous HV balloon dilatation was performed for HV stenosis on days 3, 15, 50, 55, and 270 after LDLT, respectively. Balloon dilatation followed with stent placement via superior mesenteric vein was performed for the pediatric PV stenosis 168 d after LDLT. RESULTS: The intraoperative HV tension was corrected with an air balloon. The recipient who underwent emergent reoperation for hepatic stenosis died of hemorrhagic shock and renal failure 2 d later. HV balloon dilatation via the transjugular and transfemoral venous approach was technically successful in all patients. The patient with early-onset HV stenosis receiving transjugular balloon dilatation and stent placement on the 15th postoperative day left hospital 1 A later and disappeared, while the patient receiving the same interventional procedures on the 50th postoperative day died of graft failure and renal failure 2 wk later. Two patients with late-onset HV stenosis receiving balloon dilatation have survived for 8 and 4 mo without recurrent stenosis and ascites, respectively. Balloon dilatation and stent placement via the superior mesenteric venous approach was technically successful in the pediatric left lobe LDLT, and this patient has survived for 9 mo without recurrent PV stenosis and ascites. CONCLUSION: Intraoperative balloon placement, emergent reoperation, proper interventional balloon dilatation and stent placement can be effective as a way to manage hepatic and PV stenosis during and after LDLT.
引用
收藏
页码:4969 / 4973
页数:5
相关论文
共 50 条
  • [41] Living donor liver transplantation and management of portal venous pressure
    Busani, S.
    Marconi, G.
    Schiavon, L.
    Rinaldi, L.
    Del Buono, M.
    Masetti, M.
    Girardis, M.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (04) : 1074 - 1075
  • [42] Donor-Specific HLA Antibodies in Living Versus Deceased Donor Liver Transplant Recipients
    Levitsky, J.
    Kaneku, H.
    Jie, C.
    Walsh, R. C.
    Abecassis, M.
    Tambur, A. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (08) : 2437 - 2444
  • [43] Cytokine concentrations and regulatory T cells in living donor and deceased donor liver transplant recipients
    Briem-Richter, Andrea
    Leuschner, Alexander
    Haag, Friedrich
    Grabhorn, Enke
    Ganschow, Rainer
    PEDIATRIC TRANSPLANTATION, 2013, 17 (02) : 185 - 190
  • [44] Expression of alpha smooth muscle actin in living donor liver transplant recipients
    Masataka Hirabaru
    Kyoko Mochizuki
    Mitsuhisa Takatsuki
    Akihiko Soyama
    Taiichiro Kosaka
    Tamotsu Kuroki
    Isao Shimokawa
    Susmu Eguchi
    World Journal of Gastroenterology, 2014, (22) : 7067 - 7074
  • [45] Outcomes of Living and Deceased Donor Liver Transplant Recipients According to the MELD Score
    Lee, J. G.
    Kim, D. G.
    Lee, J. J.
    Kim, S. H.
    Lee, J. Y.
    Kwon, S. -K.
    Joo, D. J.
    Ju, M. K.
    Choi, G. H.
    Choi, J. S.
    Kim, S. I.
    Kim, M. S.
    TRANSPLANTATION, 2017, 101 (05) : 218 - 219
  • [46] Effect of hematocrit on pharmacokinetics of tacrolimus in adult living donor liver transplant recipients
    Minematsu, T
    Sugiyama, E
    Kusama, M
    Hori, S
    Yamada, Y
    Ohtani, H
    Sawada, Y
    Sato, H
    Takayama, T
    Sugawara, Y
    Makuuchi, M
    Iga, T
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (05) : 1506 - 1511
  • [47] Management of arterial complications following living donor liver transplant
    Semash, Konstantin
    Dzhanbekov, Timur
    TRANSPLANTATION, 2024, 108 (9S)
  • [48] Management of arterial complications following living donor liver transplant
    Semash, Konstantin
    Dzhanbekov, Timur
    TRANSPLANTATION, 2024, 108 (09) : 631 - 631
  • [49] De novo malignancies in 1639 consecutive living donor liver transplant recipients
    Tiwari, A.
    Saigal, S.
    Chaudhary, N.
    Saraf, N.
    Saha, S.
    Rastogi, A.
    Goja, S.
    Bhangui, P.
    Nundy, S.
    Soin, A. S.
    TRANSPLANTATION, 2018, 102 : 182 - 183
  • [50] Tacrolimus dosing requirements and concentrations in adult living donor liver transplant recipients
    Taber, DJ
    Dupuis, RE
    Fann, AL
    Andreoni, KA
    Gerber, DA
    Fair, JH
    Johnson, MW
    Shrestha, R
    LIVER TRANSPLANTATION, 2002, 8 (03) : 219 - 223